Radiotherapy & Oncology
Volume 87, Issue 1 , Pages 24-28 , April 2008

Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer – report on clinical outcome and dose to critical organs

Received 25 September 2007 ,Revised 12 February 2008 ,Accepted 14 February 2008.

References 

  1. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109:120–129
  2. Sawada S, Komori E, Yamashita M, et al. Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancer – retrospective analysis focused on a histological subgroup. Surg Endosc. 2007;21:1607–1611
  3. Sugi K, Kaneda Y, Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg. 2000;24:27–31
  4. Morita K, Fuwa N, Suzuki Y, et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol. 1997;42:31–36
  5. Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiot Oncol Biol Phys. 1998;40:149–154
  6. Blomgren H, Lax I, Goeransson H, et al. Radiosurgery for tumor in the body: clinical experience using a new methods. J Radiosurg. 1998;1:63–74
  7. Perez CA, Stanley K, Rubin P, et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-small cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group. Cancer. 1988;45:2744–2753
  8. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma. Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623–1631
  9. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiot Oncol Biol Phys. 2005;63:1010–1015
  10. Wulf J, Baier K, Mueller G, Flentje MP. Dose–response in stereotactic irradiation of lung tumor. Radiother Oncol. 2005;77:83–87
  11. Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiot Oncol Biol Phys. 2003;56:126–135
  12. Wulf J, Hädinger U, Oppitz , et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol. 2001;177:645–655Abstract
  13. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiot Oncol Biol Phys. 1991;21:109–122
  14. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a 5-year experience. Int J Radiot Oncol Biol Phys. 2001;51:666–670
  15. Fukumoto S, Shirato H, Shimzu S, et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinoma. Cancer. 2002;95:1546–1553
  16. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiot Oncol Biol Phys. 2004;60:186–196
  17. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiot Oncol Biol Phys. 2005;63:1427–1431
  18. Nyman J, Johansson KA, Hultén U. Stereotactic hypofractionated radiotherapy of stage I non-small cell lung cancer – mature results for medically inoperable patients. Lung Cancer. 2006;51:97–103
  19. Bergman B, Chevalier TL, Pignon JP, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Eng J Med. 2004;350:351–360
  20. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer. N Eng J Med. 2005;352:2589–2597
  21. Douillard JY, Rosell R, Lena ME, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7:719–727
  22. Hoyer M, Roed H, Hansen AT, et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiot Oncol Biol Phys. 2006;66:S128–S135

PII: S0167-8140(08)00108-4

doi: 10.1016/j.radonc.2008.02.015

Radiotherapy & Oncology
Volume 87, Issue 1 , Pages 24-28 , April 2008

Article Tools